関連する実験動画

Updated: May 4, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.8K

高リスクの局所性前立腺がんの男性におけるアジュバントルプロレリンアセテートを評価するランダム化第3相AFU-GETUG-20試験の結果

François Rozet1, Alain Ruffion2, Pablo Lemercier3

  • 1Department of Urology, Institut Mutualiste Montsouris, Paris, France.

European urology oncology
|January 4, 2026
PubMed
まとめ

No abstract available in PubMed .

キーワード:
AFU-GETUG-20 についてゴナドトロピン放出ホルモン受容体アゴニスト高リスク 前立腺がんアンドロゲン欠乏療法レウプロレリンアセテート前立腺の切除検知できない前立腺特異抗原レベル

さらに関連する動画

Retzius-Sparing Robot-Assisted Radical Prostatectomy12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.9K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

628

関連する概念動画

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K